about
miRNAs Regulation and Its Role as Biomarkers in EndometriosisGuidelines for the design, analysis and interpretation of 'omics' data: focus on human endometriumIdentification and characterization of microRNAs expressed in the African malaria vector Anopheles funestus life stages using high throughput sequencingEmbryonic miRNA profiles of normal and ectopic pregnancies.Human myometrium - the ultrastructural 3D network of telocytes.Identification and characterization of novel serum microRNA candidates from deep sequencing in cervical cancer patientsCell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissuesPeritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.Somatic stem cells and their dysfunction in endometriosis.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.Non-coding RNAs in Uterine Development, Function and Disease.The biological significance and clinical applications of exosomes in ovarian cancer.Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis.Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis.Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?MicroRNAs Involved in Anti-Tumour Immunity.Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives.Endometriosis and cancer.Intercellular Signaling in Cancer-the SMT and TOFT Hypotheses, Exosomes, Telocytes and Metastases: Is the Messenger in the Message?MicroRNA expression profiling in endometriosis-associated infertility and its relationship with endometrial receptivity evaluated by ultrasound.Dicer1 dysfunction promotes stemness and aggression in endometrial carcinoma.miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1.MicroRNA expression analysis in endometriotic serum treated mesenchymal stem cells.Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation.Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.Identification of microRNAs as potential markers of ovarian toxicity.MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.Discovery of biomarkers for endometrial cancer: current status and prospects.
P2860
Q26771724-57FCC933-1443-4EB3-9D79-D8C3B235B5B3Q27012789-4848B288-CAAD-4DD8-AC54-2919AE553A32Q28596075-51E788A5-9DC1-44A1-9E89-3D120AA30590Q33889915-5169D93B-A709-420D-997C-108EA183567DQ33986032-D1C5DF9B-6207-4276-A5CF-2E479480CFEAQ34124454-9F6BE844-26B0-43AB-A799-A5419860F81CQ34426839-9C666B71-30E0-46A4-BC8A-B61973B1D537Q34489328-178139DA-B008-4E8B-86CC-27CA8F91396FQ34689624-8B94150B-5B4C-4203-8A26-F115B58ABDC9Q34867890-1D16DC76-DED7-4BC5-BF60-440B2BC7C251Q35125641-FF28788F-EC7B-495E-A523-4AB0B4A2FA87Q36426116-6C08C7F0-CF3C-4C35-976D-F2936B75EA01Q36930853-9688AF10-ACD0-48E1-BF79-F5024431AD87Q37029851-4AC71173-22F9-460A-B8C4-E6975881D657Q37361635-BCAE809A-42FE-4E4E-8CE2-F494E3A02730Q37404639-5EE88B86-C436-4208-8112-433ACC276E2FQ37702543-03094378-1868-4F3A-9210-715A8461629CQ38088117-11650C08-92B8-4571-9FFC-8A96ED9D4E86Q38141097-CD364679-300F-4650-BF0A-1B2FD54F4DE6Q38284360-28E7CA4A-60B0-4449-8222-FDA87436A5D5Q38528913-85CADA1C-568B-47C7-9707-8BBC23640D72Q38683664-789E1D5D-99CF-4998-983D-BB1841240E67Q38708768-4EBF9A57-AA0E-4D3B-876A-F2ABDC4D3DB2Q38972688-37635B98-04D6-4695-9416-4B51786558B4Q39052219-AF879167-47A2-409B-BE0B-F67008D88A8EQ41290520-72B14746-1357-499F-B647-1A5CEF0A9FC6Q43412551-9A654CA6-916D-468F-AEF2-7C5BAFB06492Q47547453-41AD364B-F04A-46D3-8443-6B1E9CADD6B9Q47548469-1A416A46-46E4-4260-AF2D-C5B701C39DD9Q50477507-6AFEEDBA-B12E-47E2-BA2A-51ED1D295615Q51341963-8F1AF061-7B0B-40FE-B732-FB3035BB209A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of microRNAs in gynecological pathology.
@en
Role of microRNAs in gynecological pathology.
@nl
type
label
Role of microRNAs in gynecological pathology.
@en
Role of microRNAs in gynecological pathology.
@nl
prefLabel
Role of microRNAs in gynecological pathology.
@en
Role of microRNAs in gynecological pathology.
@nl
P2093
P1476
Role of microRNAs in gynecological pathology
@en
P2093
A Estelles
J Gilabert-Estelles
P304
P356
10.2174/092986712800269362
P577
2012-01-01T00:00:00Z